Fuller Rw

675 total citations
49 papers, 556 citations indexed

About

Fuller Rw is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biochemistry. According to data from OpenAlex, Fuller Rw has authored 49 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 10 papers in Biochemistry. Recurrent topics in Fuller Rw's work include Neurotransmitter Receptor Influence on Behavior (16 papers), Neuroscience and Neuropharmacology Research (8 papers) and Amino Acid Enzymes and Metabolism (6 papers). Fuller Rw is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (16 papers), Neuroscience and Neuropharmacology Research (8 papers) and Amino Acid Enzymes and Metabolism (6 papers). Fuller Rw collaborates with scholars based in United States and United Kingdom. Fuller Rw's co-authors include Saunders Kb and has published in prestigious journals such as Toxicology and Applied Pharmacology, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Fuller Rw

49 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fuller Rw United States	12	257	116	115	112	86	49	556
M Hauptmann Poland	17	449 1.7×	102 0.9×	66 0.6×	227 2.0×	102 1.2×	33	641
A Kamoun France	13	236 0.9×	139 1.2×	189 1.6×	136 1.2×	78 0.9×	29	578
Bruce I. Diamond United States	14	306 1.2×	81 0.7×	170 1.5×	141 1.3×	50 0.6×	27	721
L. Oreland Sweden	15	327 1.3×	40 0.3×	68 0.6×	178 1.6×	67 0.8×	33	706
Åsa Wiberg Sweden	5	219 0.9×	42 0.4×	140 1.2×	95 0.8×	28 0.3×	6	511
J. Dedek France	15	528 2.1×	111 1.0×	44 0.4×	305 2.7×	99 1.2×	18	750
Yasuyuki Ichimaru Japan	11	303 1.2×	46 0.4×	106 0.9×	229 2.0×	80 0.9×	42	560
I.H. Ayhan Türkiye	12	349 1.4×	54 0.5×	151 1.3×	133 1.2×	43 0.5×	24	558
I Zebrowska-Łupina Poland	12	239 0.9×	136 1.2×	49 0.4×	132 1.2×	99 1.2×	43	450
P.H. Hutson United States	14	408 1.6×	70 0.6×	69 0.6×	246 2.2×	46 0.5×	21	671

Countries citing papers authored by Fuller Rw

Since Specialization

Citations

This map shows the geographic impact of Fuller Rw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuller Rw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuller Rw more than expected).

Fields of papers citing papers by Fuller Rw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuller Rw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuller Rw. The network helps show where Fuller Rw may publish in the future.

Co-authorship network of co-authors of Fuller Rw

This figure shows the co-authorship network connecting the top 25 collaborators of Fuller Rw. A scholar is included among the top collaborators of Fuller Rw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuller Rw. Fuller Rw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rw, Fuller. (1992). The involvement of serotonin in regulation of pituitary-adrenocortical function.. PubMed. 13(3). 250–70. 153 indexed citations

Rw, Fuller, et al.. (1988). AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.. PubMed. 61(2). 257–60. 3 indexed citations

Rw, Fuller, et al.. (1987). Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.. PubMed. 58(3). 409–12. 21 indexed citations

Rw, Fuller. (1986). Substituted phenylpiperazines as serotonin agonists: structural determinants of potency and interaction with receptor subtypes.. PubMed. 22(3). 825–8. 4 indexed citations

Rw, Fuller. (1986). Biochemical pharmacology of the serotonin system.. PubMed. 43. 469–80. 13 indexed citations

Rw, Fuller, et al.. (1984). Central serotonin antagonist activity of ketanserin.. PubMed. 46(1). 151–4. 8 indexed citations

Rw, Fuller, et al.. (1983). A cumulative dose response study of oxitropium bromide (Ba 253) in asthmatics.. PubMed. 128 (Pt 2). 536–9. 4 indexed citations

Rw, Fuller. (1982). Functional consequences of inhibiting serotonin uptake with fluoxetine in rats.. PubMed. 34. 219–28. 8 indexed citations

Rw, Fuller, et al.. (1981). Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats.. PubMed. 34(1). 137–40. 5 indexed citations

10.

Rw, Fuller, et al.. (1980). Comparison of some conformationally rigid benzylamine analogs as substrates for rabbit lung N-methyltransferase.. PubMed. 30(3). 401–8. 1 indexed citations

11.

Rw, Fuller, et al.. (1980). Ihibition of rat brain norepinephrine N-methyltransferase in vitro and in vivo by chloro-substituted 1-aminoindans.. PubMed. 27(3). 485–95. 1 indexed citations

12.

Rw, Fuller, et al.. (1979). Inability of imipramine to protect against type A or type B monoamine oxidase inhibition by pargyline.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(2). 411–4. 2 indexed citations

13.

Rw, Fuller, et al.. (1978). Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(3). 581–584. 1 indexed citations

14.

Rw, Fuller, et al.. (1977). Effect of p-chloroamphetamine on serotonin content of the rat pineal gland.. PubMed. 18(4). 769–72. 4 indexed citations

15.

Rw, Fuller. (1975). Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors. Toxicology and Applied Pharmacology. 32(1). 129–134. 9 indexed citations

16.

Rw, Fuller, et al.. (1974). 6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in rats.. PubMed. 212(1). 141–53. 8 indexed citations

17.

Rw, Fuller, et al.. (1973). Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats.. PubMed. 6(2). 407–18. 2 indexed citations

18.

Rw, Fuller. (1972). Selective inhibition of monoamine oxidase.. PubMed. 5. 339–54. 21 indexed citations

19.

Rw, Fuller. (1968). Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.. PubMed. 174(1). 32–7. 13 indexed citations

20.

Rw, Fuller, et al.. (1962). Hypertelorism in association with chromatin sex abnormality in two siblings.. PubMed. 66. 844–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact